Fahn S - Search Results

1

Description of Parkinson's disease as a clinical syndrome.

Fahn S. Fahn S. Ann N Y Acad Sci. 2003 Jun;991:1-14. doi: 10.1111/j.1749-6632.2003.tb07458.x. Ann N Y Acad Sci. 2003. PMID: 12846969 Review.

2

Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features.

Giladi N, Burke RE, Kostic V, Przedborski S, Gordon M, Hunt A, Fahn S. Giladi N, et al. Among authors: fahn s. Neurology. 1990 Nov;40(11):1731-4. doi: 10.1212/wnl.40.11.1731. Neurology. 1990. PMID: 2234429

3

Hoehn and Yahr stage 3 and postural stability item in the movement disorder society-unified Parkinson's disease rating scale.

Gupta DK, Fahn S, Tatsuoka C, Kang UJ. Gupta DK, et al. Among authors: fahn s. Mov Disord. 2018 Jul;33(7):1188-1189. doi: 10.1002/mds.27453. Mov Disord. 2018. PMID: 30153396 No abstract available.

4

SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease.

Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS, Ambalavanan A, Laurent SB, Spiegelman D, Dionne-Laporte A, Liong C, Levy OA, Fahn S, Waters C, Kuo SH, Chung WK, Ford B, Marder KS, Kang UJ, Hassin-Baer S, Greenbaum L, Trempe JF, Wolf P, Oliva P, Zhang XK, Clark LN, Langlois M, Dion PA, Fon EA, Dupre N, Rouleau GA, Gan-Or Z. Alcalay RN, et al. Among authors: fahn s. Mov Disord. 2019 Apr;34(4):526-535. doi: 10.1002/mds.27642. Epub 2019 Feb 20. Mov Disord. 2019. PMID: 30788890 Free PMC article.

5

A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.

Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I; Parkinson Study Group LABS-PD Investigators. Ravina B, et al. Among authors: fahn s. Mov Disord. 2009 Oct 30;24(14):2081-90. doi: 10.1002/mds.22690. Mov Disord. 2009. PMID: 19691116

6

Oliver Sacks, MD, 1933-2015.

Fahn S. Fahn S. Mov Disord. 2016 Apr;31(4):493-6. doi: 10.1002/mds.26602. Mov Disord. 2016. PMID: 27079682 No abstract available.

7

Masaya Segawa, MD, PhD, 1936-2014.

Nomura Y, Fahn S. Nomura Y, et al. Among authors: fahn s. Mov Disord. 2015 Jun;30(7):883-5. doi: 10.1002/mds.26257. Epub 2015 May 23. Mov Disord. 2015. PMID: 26009805 No abstract available.

8

Levodopa: 50 years of a revolutionary drug for Parkinson disease.

Fahn S, Poewe W. Fahn S, et al. Mov Disord. 2015 Jan;30(1):1-3. doi: 10.1002/mds.26122. Epub 2014 Dec 8. Mov Disord. 2015. PMID: 25488146 No abstract available.

9

Classification of movement disorders.

Fahn S. Fahn S. Mov Disord. 2011 May;26(6):947-57. doi: 10.1002/mds.23759. Mov Disord. 2011. PMID: 21626541 Review.

10

Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes.

Gilbert RM, Fahn S, Mitsumoto H, Rowland LP. Gilbert RM, et al. Among authors: fahn s. Mov Disord. 2010 Sep 15;25(12):1868-75. doi: 10.1002/mds.23200. Mov Disord. 2010. PMID: 20669307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results